Stem cell-based strategies for the treatment of type 1 diabetes mellitus

By Wen Yujie   Chen Bo   Ildstad Suzanne T  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 1, 2011-01 ,pp. : 41-53

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes

By Louise A. Scrocchi  

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 545-551

Springer Publishing Company

Access to resources Recommend Favorite

Treg in type 1 diabetes

By Brusko Todd   Atkinson Mark  

Cell Biochemistry and Biophysics, Vol. 48, Iss. 2-3, 2007-07 ,pp. : 165-175

Humana Press, Inc

Access to resources Recommend Favorite

Transcriptome meta-analysis of peripheral lymphomononuclear cells indicates that gestational diabetes is closer to type 1 diabetes than to type 2 diabetes mellitus

By Collares C.   Evangelista A.   Xavier D.   Takahashi P.   Almeida R.   Macedo C.   Manoel-Caetano F.   Foss M.   Foss-Freitas M.   Rassi D.   Sakamoto-Hojo E.   Passos G.   Donadi E.  

Molecular Biology Reports, Vol. 40, Iss. 9, 2013-09 ,pp. : 5351-5358

Springer Publishing Company

Access to resources Recommend Favorite

Rebuttal to Deacon and Holst: “Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1” versus “Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective”

By Demuth H-U.   Hinke S.A.   Pederson R.A.   McIntosh C.H.S.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 2, 2002-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite